ORIGINAL ARTICLE |
|
Year : 2013 | Volume
: 8
| Issue : 4 | Page : 155-160 |
|
Evaluation of dyslipidaemia in patients with rheumatoid arthritis in South Indian population
Kiranmayi S Vinapamula1, Suchitra M Manohar1, Aparna R Bitla1, Rajyalakshmi Kanduri1, Siddartha Kumar Bhattaram2, Srinivasa Rao V. L .N. Pemmaraju1
1 Department of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati 517507, India 2 Department of Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati 517507, India
Correspondence Address:
Srinivasa Rao V. L .N. Pemmaraju Department of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati 517507 India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.1016/j.injr.2013.06.006
|
|
Background: Rheumatoid arthritis (RA) is associated with increased cardiovascular morbidity and mortality which is mainly due to accelerated atherosclerosis. The inflam- mation in rheumatoid arthritis is likely to alter the lipid profile in these patients resulting in dyslipidaemia which is an important cardiovascular disease (CVD) risk factor.
Material and methods: 46 patients diagnosed with RA as per 1987 revised American Rheu- matology Association criteria were included in the study. Of the 46 patients, 24 were newly diagnosed RA patients and 22 patients were undergoing treatment with a combination of DMARDs with (n ¼ 14) or without (n ¼ 8) corticosteroids. 46 age and sex matched healthy subjects were included as controls. Total cholesterol (TC), triglycerides, HDL cholesterol, lDL cholesterol, apolipoprotein A-1 (apo A-1), apolipoprotein B (apo B) and lipoprotein(a) (Lp(a)) were measured.
Results: TC, HDL cholesterol and LDL cholesterol levels were similar in all the three study groups. Both groups of patients had significantly elevated triglyceride, apo B and Lp(a) levels compared to controls ( p < 0.05). RA patients undergoing treatment had significantly elevated apo A-1 levels when compared to controls ( p < 0.05).
Conclusions: The dyslipidaemia pattern in RA patients in the present study is evident in the form of elevated triglycerides, apo B and Lp(a) levels. The beneficial effects of a higher atheroprotective apo A-1 in patients undergoing treatment may be counteracted by the presence of high triglycerides, apo B and Lp(a). |
|
|
|
[PDF]* |
|
 |
|